Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4FZC

20S yeast proteasome in complex with cepafungin I

4FZC の概要
エントリーDOI10.2210/pdb4fzc/pdb
関連するPDBエントリー1RYP 2ZCY
関連するBIRD辞書のPRD_IDPRD_001018
分子名称Proteasome component Y7, Proteasome component C11, Proteasome component PRE2, ... (16 entities in total)
機能のキーワードubiquitin, proteasome, drug development, inhibitor, natural product, n-terminal nucleophilic hydrolase, protein degradation, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
由来する生物種Saccharomyces cerevisiae (Baker's yeast)
詳細
タンパク質・核酸の鎖数32
化学式量合計706425.12
構造登録者
Stein, M.,Beck, P.,Kaiser, M.,Dudler, R.,Becker, C.F.W.,Groll, M. (登録日: 2012-07-06, 公開日: 2012-10-24, 最終更新日: 2023-11-15)
主引用文献Stein, M.L.,Beck, P.,Kaiser, M.,Dudler, R.,Becker, C.F.,Groll, M.
One-shot NMR analysis of microbial secretions identifies highly potent proteasome inhibitor.
Proc.Natl.Acad.Sci.USA, 109:18367-18371, 2012
Cited by
PubMed Abstract: Natural products represent valuable lead structures for drug discovery. However, for most bioactive compounds no cellular target is yet identified and many substances predicted from genome analysis are inaccessible due to their life stage-dependent biosynthesis, which is not reflected in common isolation procedures. In response to these issues, an NMR-based and target-directed protease assay for inhibitor detection of the proteasome was developed. The methodology is suitable for one-shot identification of inhibitors in conglomerates and crude culture broths. The technique was applied for analysis of the different life stages of the bacterium Photorhabdus luminescens, which resulted in the isolation and characterization of cepafungin I (CepI), the strongest proteasome inhibitor described to date. Its biosynthesis is strictly regulated and solely induced by the specific environmental conditions determined by our methodology. The transferability of the developed technique to other drug targets may disclose an abundance of novel compounds applicable for drug development.
PubMed: 23091006
DOI: 10.1073/pnas.1211423109
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.8 Å)
構造検証レポート
Validation report summary of 4fzc
検証レポート(詳細版)ダウンロードをダウンロード

237423

件を2025-06-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon